Purdue, Ocular partner to develop non-opioid therapies

Purdue Pharma L.P. (Stamford, Conn.) and Ocular Therapeutix Inc. (NASDAQ:OCUL) will partner to develop and commercialize Purdue's non-opioid new chemical entities with Ocular's bioresorbable hydrogel-based technology. Ocular is responsible for discovery and bringing a product to Phase I testing...